-
EP1140891
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1140891
| EP1140891 - 1,4-DIAZACYCLOHEPTANE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 15.11.2002 Database last updated on 12.06.2024 | Most recent event Tooltip | 15.11.2002 | Application deemed to be withdrawn | published on 02.01.2003 [2003/01] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2001/41] | Inventor(s) | 01 /
CHAUDHARI, Bipinchandra, Bhudharlal 1800 Concord Pike Wilmington, DE 19850-5437 / US | 02 /
SIMON-BIERENDAUM, Richard, Elliot 1800 Concord Pike Wilmington, DE 19850-5437 / US | 03 /
KEITH, Richard, Alan 1800 Concord Pike Wilmington, DE 19850-5437 / US | 04 /
WARAWA, Edward, John 1800 Concord Pike Wilmington, DE 19850-5437 / US | 05 /
MCLAREN, Charles, David 1800 Concord Pike Wilmington, DE 19850-5437 / US | [2001/41] | Application number, filing date | 99964753.0 | 21.12.1999 | [2001/41] | WO1999GB04351 | Priority number, date | GB19990000078 | 05.01.1999 Original published format: GB 9900078 | [2001/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0040574 | Date: | 13.07.2000 | Language: | EN | [2000/28] | Type: | A1 Application with search report | No.: | EP1140891 | Date: | 10.10.2001 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.07.2000 takes the place of the publication of the European patent application. | [2001/41] | Search report(s) | International search report - published on: | EP | 13.07.2000 | Classification | IPC: | C07D311/68, A61K31/353, A61P25/28 | [2001/41] | CPC: |
C07D405/04 (EP);
A61P17/02 (EP);
A61P25/02 (EP);
A61P25/16 (EP);
A61P25/28 (EP);
A61P31/18 (EP);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/41] | Title | German: | 1,4-DIAZACYCLOHEPTAN-VERBINDUNEGEN, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL | [2001/41] | English: | 1,4-DIAZACYCLOHEPTANE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS | [2001/41] | French: | COMPOSES DE 1,4-DIAZACYCLO-HEPTANE, PROCEDEEDE PREPARATION ET APPLICATIONS MEDICAMENTEUSES | [2001/41] | Entry into regional phase | 06.08.2001 | National basic fee paid | 06.08.2001 | Designation fee(s) paid | 06.08.2001 | Examination fee paid | Examination procedure | 08.06.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 06.08.2001 | Examination requested [2001/41] | 14.02.2002 | Despatch of a communication from the examining division (Time limit: M04) | 25.06.2002 | Application deemed to be withdrawn, date of legal effect [2003/01] | 29.07.2002 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2003/01] | Fees paid | Renewal fee | 02.01.2002 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO9800412 (SCHERING CORP [US]) [A] 1,10,11 * claims 1,6-9,11 *; | [A]EP0856514 (HOFFMANN LA ROCHE [CH]) [A] 1,10,11 * examples 51,52; claims 1,12,13,16 *; | [A]WO9316057 (MERAM LAB [FR]) [A] 1,10 * claims 1,17; table 1 *; | [A]FR2468601 (MARUKO PHARMACEUTICAL CO [JP]) [A] 1,10 * page 5, line 15 - line 21; example 3; claim 1 *; | [A]EP0350805 (BEIERSDORF AG [DE]) [A] 1,10 * page 31, example 16; page 15, line 6 - line 13; claims 1,4 *; | [A]EP0165780 (LILLY CO ELI [US]) [A] 1,10 * page 12, compound no. 10; page 13, table 1, first compound;; claims 1,8 * |